A prestigious Centers of Biomedical Research Excellence (COBRE) grant award from the National Institutes of General Medical Sciences totaling $11.4 million will continue to fund UK’s Center for Cancer Metabolism over the next five years.
Childhood cancer rates in Kentucky appear to be higher than the national rates for several cancer types. The UK Markey Cancer Center provides leading care to children in Kentucky, identifying new mechanisms causing these cancers and developing new treatment modalities.
The report, released every five years, combines data and community perspectives that illustrate how social determinants of health, behaviors and biology intersect.
Nearly three decades after first discovering the tumor-suppressing Par-4 “super gene” that has been shown to kill cancer cells, a team of researchers at the University of Kentucky Markey Cancer Center is now learning about its role in preventing obesity.
This blog is written by B. Mark Evers, M.D., director of the University of Kentucky Markey Cancer Center, in recognition of National Cancer Research Month.
The UK Markey Cancer Center joins Caris' extensive network of leading cancer institutions committed to utilizing clinical data to advance patient care and outcomes.
There is evidence that liquid biopsies obtained from a blood sample have the potential to replace tumor biopsies requiring patients to undergo a surgical procedure.
The University of Kentucky Markey Cancer Center Foundation received a $1 million gift to create the world’s first distinguished professorship in neuroendocrine tumor (NET) research.
Junior Lauren Hudson’s passion for research started her freshman year, when Nathan Vanderford, the assistant director for research in the UK Markey Cancer Center, reached out to her about participating in his research program.
In this episode of Behind the Blue, Evers takes us through some of the most important milestones and accomplishments of the Markey team during his time at UK, and discusses plans for Markey’s future.
